Case series:Sequential CART cell immunotherapy
Sponsors
Beijing Boren Hospital, Beijing Boren Hospita
Conditions
Relapsed B acute lymphoblastic leukemia after allo-HCTprimary refractory or chemotherapeutic relapsed B-cell acute lymphoblastic leukemia
Early Phase 1
study of sequential chimeric antigen receptor T cell therapy targeting at different B-cell antigens in primary refractory or chemotherapeutic relapsed B-cell acute lymphoblastic leukemia
RecruitingChiCTR1900022190
Start: 2019-03-27Updated: 2019-04-01
Study for sequential chimeric antigen receptor T cells targeting at different B-cell antigens in relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
RecruitingChiCTR1900022209
Start: 2019-03-27Updated: 2019-04-01